The effect of ivabradine on long term prevention of major adverse cardiac events in acute coronary syndrome using high-sensitivity C-reactive protein level

Conclusion Administration of ivabradine within 48h of CCU admission decreased hs-CRP level in patients with acute coronary syndrome (unstable angina) but did not decrease the occurrence of major cardiac events in ACS patients.
Source: The Egyptian Journal of Critical Care Medicine - Category: Intensive Care Source Type: research